IL319298A - Diagnostic method for prostate cancer - Google Patents

Diagnostic method for prostate cancer

Info

Publication number
IL319298A
IL319298A IL319298A IL31929825A IL319298A IL 319298 A IL319298 A IL 319298A IL 319298 A IL319298 A IL 319298A IL 31929825 A IL31929825 A IL 31929825A IL 319298 A IL319298 A IL 319298A
Authority
IL
Israel
Prior art keywords
value
42caserum
ratios
calcium
classification
Prior art date
Application number
IL319298A
Other languages
English (en)
Hebrew (he)
Inventor
Anton Eisenhauer
Original Assignee
Geomar Helmholtz Zentrum F?R Ozeanforschung Kiel
Anton Eisenhauer
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Geomar Helmholtz Zentrum F?R Ozeanforschung Kiel, Anton Eisenhauer filed Critical Geomar Helmholtz Zentrum F?R Ozeanforschung Kiel
Publication of IL319298A publication Critical patent/IL319298A/en

Links

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/84—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving inorganic compounds or pH
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/483—Physical analysis of biological material
    • G01N33/487—Physical analysis of biological material of liquid biological material
    • G01N33/49—Blood
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/56—Staging of a disease; Further complications associated with the disease
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2800/00—Detection or diagnosis of diseases
    • G01N2800/70—Mechanisms involved in disease identification
    • G01N2800/7023—(Hyper)proliferation
    • G01N2800/7028—Cancer

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Biomedical Technology (AREA)
  • Hematology (AREA)
  • Immunology (AREA)
  • Molecular Biology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Medicinal Chemistry (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Analytical Chemistry (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • General Physics & Mathematics (AREA)
  • Biotechnology (AREA)
  • Inorganic Chemistry (AREA)
  • Cell Biology (AREA)
  • Microbiology (AREA)
  • Ecology (AREA)
  • Biophysics (AREA)
  • Other Investigation Or Analysis Of Materials By Electrical Means (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
IL319298A 2022-09-01 2023-08-29 Diagnostic method for prostate cancer IL319298A (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
DE102022122197.0A DE102022122197A1 (de) 2022-09-01 2022-09-01 Diagnosemethode für Prostatakrebs
PCT/EP2023/073662 WO2024047035A1 (de) 2022-09-01 2023-08-29 Diagnosemethode für prostatakrebs

Publications (1)

Publication Number Publication Date
IL319298A true IL319298A (en) 2025-04-01

Family

ID=89905592

Family Applications (1)

Application Number Title Priority Date Filing Date
IL319298A IL319298A (en) 2022-09-01 2023-08-29 Diagnostic method for prostate cancer

Country Status (6)

Country Link
EP (1) EP4581368A1 (de)
JP (1) JP2025538033A (de)
AU (1) AU2023331904A1 (de)
DE (1) DE102022122197A1 (de)
IL (1) IL319298A (de)
WO (1) WO2024047035A1 (de)

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE62230C (de) C. STEINBRENNER in Harn, bürg, St. Pauli, Hopfenstr. 19 Feuerfeste Decke mit Anwendung von Wellblech
JP2013528379A (ja) 2010-05-21 2013-07-11 オームクス コーポレーション Ｐｓａ酵素活性アッセイによる癌の検出
US20140273248A1 (en) * 2013-03-14 2014-09-18 Arizona Board Of Regents On Behalf Of Arizona State University Application of Ca Isotope Analysis to the Early Detection of Metastatic Cancer
US8846550B1 (en) 2013-03-14 2014-09-30 Asm Ip Holding B.V. Silane or borane treatment of metal thin films
WO2015126881A1 (en) 2014-02-19 2015-08-27 Arizona Board Of Regents On Behalf Of Arizona State University System and method for isotopic analysis of calcium using laser induced fluorescence
DE102018214660A1 (de) 2018-08-29 2020-03-05 Geomar Helmholtz-Zentrum Für Ozeanforschung Kiel Diagnosemethode für Erkrankungen die mit einer verminderten Knochendichte einhergehen

Also Published As

Publication number Publication date
AU2023331904A1 (en) 2025-04-10
EP4581368A1 (de) 2025-07-09
WO2024047035A1 (de) 2024-03-07
JP2025538033A (ja) 2025-11-21
DE102022122197A1 (de) 2024-03-07

Similar Documents

Publication Publication Date Title
EP4424704A2 (de) Multiplex-biomarker zur verwendung bei der beurteilung des akkumulationszustands von amyloid b im gehirn und analyseverfahren für besagte beurteilung
Alfaro et al. Intraoperative assessment of isocitrate dehydrogenase mutation status in human gliomas using desorption electrospray ionization–mass spectrometry
Hines et al. Detection of IGF-1 protein variants by use of LC-MS with high-resolution accurate mass in routine clinical analysis
US20130065266A1 (en) Disease Diagnosis Method, Marker Screening Method and Marker Using TOF-SIMS
US20180299448A1 (en) Colorectal cancer screening method
US20200064349A1 (en) Prostate cancer diagnostic biomarker composition including kynurenine pathway's metabolites
Abegg et al. Mg 24 states observed via ne 20 (α, α 0) 20 ne
US20120142558A1 (en) Diagnostic lung cancer panel and methods for its use
Yin et al. Establishment of a rapid and simple liquid chromatography tandem mass spectrometry method for measuring aldosterone in urine
IL319298A (en) Diagnostic method for prostate cancer
Navaglia et al. Pancreatic cancer biomarkers discovery by surface-enhanced laser desorption and ionization time-of-flight mass spectrometry.
EP4414709A1 (de) Diagnostischer biomarker für krebs und verwendung davon
WO2009061412A1 (en) Methods for detecting or monitoring cancer using lpe as a marker
CN101685080B (zh) 一种生物样品中蛋白质组的分析方法
US20140336281A1 (en) SRM/MRM Assay for the Ephrin Typa-A Receptor 2 Protein
CN116338210B (zh) 用于诊断原发性中枢神经系统淋巴瘤的生物标志物及检测试剂盒
KR102808116B1 (ko) 감소된 뼈 밀도에 의해 동반된 질환에 대한 진단 방법
Xiao et al. Analysis of the urinary peptidome associated with Helicobacter pylori infection
Jørgensen et al. Processing-independent analysis in the diagnosis of gastrinomas
KR102200233B1 (ko) 엑소좀 검출 및 간질환 진단을 위한 분석 방법
US20130090550A1 (en) Methods of identifying patients with ovarian epithelial neoplasms based on high-resolution mass spectrometry
US20030101004A1 (en) Lipoprotein assay
Satoh et al. Identifying the primary tumor site and distinguishing false-positives in patients with elevated serum carcinoembryonic antigen
Yang et al. Should we Continue to Monitor or Choose to Ignore the Mild Increase in CA19-9 after Surgery.
Wilz et al. Development of a test to identify bladder cancer in the urine of patients using mass spectroscopy and subcellular localization of the detected proteins